Transcription from the human asparagine synthetase (AS) gene is increased in response to either amino acid (amino acid response) or glucose (unfolded protein response) deprivation. These two independent pathways converge on the same set of genomic cis-elements within the AS promoter, which are referred to as nutrient-sensing response element (NSRE)-1 and -2, both of which are absolutely necessary for gene activation. The NSRE-1 sequence was used to identify the corresponding transcription factor by yeast one-hybrid screening. Based on those results, electrophoretic mobility shift assays for individual CCAAT/enhancer-binding protein-␤ (C/EBP) family members were performed to test for supershifting of complexes by specific antibodies. The results indicated that of all the family members, C/EBP␤ bound to the NSRE-1 sequence to the greatest extent and that the absolute amount of this complex was increased when extracts from amino acid-or glucose-deprived cells were tested. Using electrophoretic mobility shift assays, mutation of the NSRE-1 sequence completely prevented formation of the C/EBP␤-containing complexes. In contrast, mutation of the NSRE-2 sequence did not block C/EBP␤ binding. Overexpression in HepG2 hepatoma cells of the activating isoform of C/EBP␤ increased AS promoter-driven transcription, whereas the inhibitory dominant-negative isoform of C/EBP␤ blocked enhanced transcription following amino acid or glucose deprivation. Collectively, the results provide both in vitro and in vivo evidence for a role of C/EBP␤ in the transcriptional activation of the AS gene in response to nutrient deprivation.
Amino acid availability is clearly an important factor in general nutrition, particularly during development (1) , as well as in the progression of a wide range of diseases, including diabetes (2), kwashiorkor (3) , and hepatic encephalopathy (4) , and in cancer chemotherapy. With regard to the latter, asparagine starvation, induced by administration of the enzyme L-asparaginase, is included in all accepted protocols for the treatment of childhood acute lymphoblastic leukemia (5) . However, the impact of amino acid availability on the control of fundamental cellular processes is just beginning to be investigated extensively (reviewed in Refs. 6 and 7). A number of laboratories have identified specific mRNAs, proteins, and cellular activities that are induced following amino acid deprivation (reviewed in Refs. 7 and 8 ). An example is asparagine synthetase (AS), 1 which catalyzes the glutamine-and ATP-dependent conversion of aspartic acid to asparagine. Nearly 2 decades ago, Arfin et al. (9, 10) showed that asparagine starvation of Chinese hamster ovary cells decreases the level of asparaginyl-tRNA Asn , and subsequently, AS enzymatic activity increases; refeeding these cells asparagine rapidly reverses this response. Induction of the AS activity also occurs in temperature-sensitive Chinese hamster ovary cell mutants for asparaginyl-, leucyl-, methionyl-, and lysyl-tRNA synthetases (10) . Consistent with these data, starvation of HeLa or HepG2 hepatoma cells for any one of a number of individual amino acids causes the accumulation of AS mRNA, documenting that this nutrient-sensing mechanism broadly detects amino acid availability (11) (12) (13) .
Guerrini et al. (14) were the first to document the presence of a genomic element, within the human AS promoter, that mediates amino acid-dependent regulation of transcription. Using deletion analysis and scanning mutagenesis in conjunction with transient transfection, these authors identified a region from nt Ϫ70 to Ϫ62 that functions as an amino acid response element (AARE). Electrophoretic mobility shift assays (EMSAs) using oligonucleotides containing this sequence documented the formation of specific protein-DNA complexes in vitro (14) . The sequence within this region does not correspond precisely to a consensus sequence for any known transcription factors.
Subsequently, Barbosa-Tessmann et al. (15) (16) (17) demonstrated that the human AS gene is also induced by glucose deprivation and that this process is mediated by the unfolded protein response (UPR) pathway. Through the use of in vivo footprinting and single-nucleotide mutagenesis, it was demonstrated that the promoter sequence 5Ј-TGATGAAAC-3Ј (nt Ϫ68 to Ϫ60), the region first identified by Guerrini et al. (14) , is also responsible for induction of the AS gene following activation of the UPR pathway (17) . UPR pathway activation demonstrates that this sequence serves in a broader capacity than simply as an AARE; and, to reflect this broader substrate-detecting capability, this sequence has been labeled nutrient-sensing re-sponse element (NSRE)-1. A second element (5Ј-GTTACA-3Ј, nt Ϫ48 to Ϫ43), 11 nucleotides downstream, is also absolutely required for activation of the gene by the nutrient-sensing response pathway (17) and is referred to as NSRE-2. The term nutrient-sensing response unit has been coined to describe the collective function of these sequences.
The C/EBP homology protein (CHOP) is a member of the C/EBP family (18) , and Bruhat et al. (19, 20) have identified, within the promoter of the human CHOP gene, a sequence (5Ј-TGATGCAAT-3Ј, nt Ϫ302, order to Ϫ310) that functions as an AARE and differs by only two nucleotides from the NSRE-1 sequence in the AS promoter. Although transcription from the CHOP gene is also induced by the UPR pathway, an NSRE-2 sequence is not present; and, unlike the AS gene, the CHOP promoter has a separate sequence (5Ј-CCAATCAGAAAGTG-GCACG-3Ј, nt Ϫ75 to Ϫ93) that mediates the activation by the UPR pathway (21) . Therefore, the mechanisms for activation of these two genes by the amino acid response (AAR) and UPR pathways are distinct. Consistent with this proposal, Jousse et al. (13) have documented that transcriptional control of a reporter gene driven by the AS and CHOP promoters responds differently when cells are deprived of selected individual amino acids.
This study was designed to identify transcription proteins capable of binding to NSRE-1 of the AS promoter and to establish their role with regard to induction of the gene by the AAR and UPR pathways. Using the NSRE-1 sequence as bait, yeast onehybrid screening indicated that members of the C/EBP family bind this element. Among the members of the C/EBP family, antibodies specific for C/EBP␤ caused the greatest amount of a supershifted complex, and the abundance of this complex was increased when extracts from amino acid-or glucose-deprived cells were used. Mutation of individual nucleotides within the NSRE-1 sequence known to be critical for regulated transcription (16, 17) caused loss of C/EBP␤ binding. Expression of the activating isoform (liver-enriched activating protein (LAP)) of C/EBP␤ in HepG2 cells caused increased transcription from an AS promoter/luciferase reporter construct, whereas expression of the dominant-negative C/EBP␤ isoform (liver-enriched inhibitory protein (LIP)) blocked transcriptional induction following activation of either the AAR or UPR pathway. Collectively, the results demonstrate that C/EBP␤ binds in vitro to NSRE-1 within the human AS promoter and is able to regulate AS promoter-driven transcription in vivo.
MATERIALS AND METHODS
Cell Culture-Human HepG2 hepatoma cells were cultured in minimal essential medium (MEM), pH 7.4, supplemented with 25 mM NaHCO 3 , 4 mM glutamine, 10 g/ml streptomycin sulfate, 100 g/ml penicillin G, 28.4 g/ml gentamycin, 0.023 g/ml N-butyl-p-hydroxybenzoate, 0.2% (w/v) bovine serum albumin, and 10% (v/v) fetal bovine serum. Cells were maintained at 37°C in a 5% CO 2 and 95% air incubator.
Transient Transfection and Northern Analysis-HepG2 cells were cotransfected with a reporter plasmid composed of firefly luciferase (pGL3 vector, Promega, Madison, WI) driven by human AS promoter sequence Ϫ115 to ϩ1 and, where indicated, the pSCT vector containing either the activating (LAP) or dominant-negative (LIP) isoform of rat C/EBP␤, originally described by Descombes and Schibler (22) and kindly provided by Dr. Harry S. Nick (University of Florida). Transfection efficiency was monitored by cotransfection with the Renilla luciferase reporter (phRL-SV40) driven by the SV40 promoter (Promega). The cells were transfected to 50 -70% confluence in 24-well plates using the batch transfection technique described by Barbosa-Tessmann et al. (16) . After transfection and a subsequent 24-h incubation in MEM, cells from each well were divided into multiple wells of a new 24-well plate and cultured for another 24 h prior to incubation for 12 h in complete MEM, histidine-free MEM, or glucose-free MEM, each supplemented with 10% dialyzed fetal bovine serum (15, 16) . In this way, cells incubated in the three different nutrient media arose from the same transfection. The firefly and Renilla luciferase activities were assayed by the dual-luciferase reporter system (Promega) according to the manufacturer's directions. The data are expressed as the means Ϯ S.D. of three to four assays, and each experiment was repeated with multiple batches of cells.
Total cellular RNA was isolated using an RNeasy minikit (QIAGEN Inc., Valencia, CA) according to the procedure described by the supplier. 32 P-Radiolabeled cDNA probe synthesis and Northern analysis were performed as described by Aslanian et al. (23) . The probe for C/EBP␤ was the rat LIP isoform cDNA, which detected both transfected isoforms, as well as endogenous human C/EBP␤.
Yeast One-hybrid Screening-A yeast one-hybrid screening system for the identification of DNA-binding proteins was purchased from CLONTECH (Palo Alto, CA). Three tandem copies of the NSRE-1 sequence (5Ј-GCAGGCATGATGAAACTTC-3Ј) were cloned in front of the minimal promoter within the two reporter vectors pHisi-1 and pLacZi and then used to produce the corresponding stably expressing yeast strains. These two cell lines permit a dual selection using HIS3 complementation for cell growth and ␤-galactosidase activity as a secondary screen for elimination of false positives. Following selection for stable transformants, the yeast strains were transformed with a human pancreatic cDNA library fused to the yeast Gal4 activation domain. Initial positives were isolated by growth on histidine-free medium containing 45 mM 3-amino-1,2,4-triazole to reduce the background expression of HIS3 in the reporter strain. Colonies that grew in the absence of histidine were used to isolate specific clones, and then each of these clones was tested for activation of the pLacZi reporter gene by backtransformation of the appropriate yeast strain, followed by a ␤-galactosidase filter lift assay. All procedures were performed according to the manufacturer's recommendations.
Electrophoretic Mobility Shift Assay-Nuclear extracts were prepared from HepG2 cells incubated for 16 h in complete MEM (control) or in MEM lacking glucose or histidine. Nuclear extracts were prepared from four 150-mm dishes of cells, and all steps were performed at 4°C. The cells were rinsed with ice-cold phosphate-buffered saline (10 mM sodium phosphate and 0.9% sodium chloride, pH 7.5), collected by scraping in 5 ml of phosphate-buffered saline/dish, and then pelleted by centrifugation at 500 ϫ g for 10 min. After resuspension in phosphatebuffered saline, the cells were collected by centrifugation at 1160 ϫ g for 5 min. To the pellet were added 600 l of TM-2 buffer (10 mM Tris-HCl, 2 mM magnesium chloride, and 0.5 mM phenylmethylsulfonyl fluoride, pH 7.4) and 4 l of a protease inhibitor mixture stock solution (2 g each of aprotinin, leupeptin, pepstatin, N-tosylphenylalanine chloromethyl ketone, and N-tosyllysine chloromethyl ketone); Triton X-100 was added to a final concentration of 0.5%; and the mixture was incubated for an additional 5 min. The cells were lysed by gently passing through a 22-gauge needle three times and then centrifuged for 10 min at 130 ϫ g. The supernatant was carefully removed and discarded, and then 300 l of TM-2 buffer was added to the lower layer (nuclei) and gently mixed. The mixture was centrifuged for 10 min at 130 ϫ g, and the upper supernatant layer was discarded as before. To the lower layer containing the nuclei were added 800 l of nuclear extraction buffer (20 mM HEPES, 20% (v/v) glycerol, 400 mM sodium chloride, 1.5 mM magnesium chloride, 1 mM dithiothreitol, 0.2 mM EDTA, and 1 mM phenylmethylsulfonyl fluoride, pH 7.6) and 4 l of the protease inhibitor mixture. The mixture was gently mixed by constant rotation for 1 h at 4°C, and the supernatant was collected after centrifugation at 18,000 ϫ g for 10 min. This mixture was dialyzed against dialysis buffer (20 mM HEPES, 20% (v/v) glycerol, 100 mM potassium chloride, 10 mM magnesium chloride, 1 mM dithiothreitol, 0.2 mM EDTA, and 1 mM phenylmethylsulfonyl fluoride, pH 7.8) overnight at 4°C, quickly frozen in liquid nitrogen, and then stored at Ϫ70°C until used. Double-stranded oligonucleotide probes were 32 P-radiolabeled by extension of overlapping ends with Klenow fragment in the presence of [␣-
32 P]dCTP (24) . An aliquot of nuclear extract (5 g of protein) was preincubated for 20 min at 4°C in a total volume of 20 l containing 40 mM Tris, pH 7.5, 200 mM NaCl, 2 mM dithioerythritol, 10% glycerol, 0.05% Nonidet P-40, 2 g of poly(dI-dC), and 0.05 mM EDTA. Then 0.004 pmol of 32 P-radiolabeled probe (ϳ10,000 dpm) and, where indicated, unlabeled competitor oligonucleotides were added, and the incubation was continued for 20 min at room temperature. If antibody binding was to be tested, 4 g (2 l) of the indicated polyclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA) was added, and an additional incubation for 20 min at room temperature was included. After electrophoresis for 2-3 h at 200V on a 5% polyacrylamide gel with a 15% cushion on the bottom 2 cm, the gel was dried, and the results were visualized by autoradiography. All experiments were repeated with at least two independently prepared nuclear extracts.
RESULTS
Yeast One-hybrid Screening-To identify the transcription proteins that bound the NSRE-1 sequence, yeast one-hybrid screening was performed using three copies of the AS promoter NSRE-1 sequence placed in front of two independent reporter systems (HIS3 and LacZ) and a human pancreatic cDNA library fused to the Gal4 activation domain. A total of 2.51 ϫ 10 6 colonies were screened for growth on histidine-free plates, and seven colonies were judged to be potential positives based on growth rate. DNA from each of the seven positives was isolated and used to perform a back-transformation. The positive colonies were then subjected to a ␤-galactosidase filter lift assay as a secondary screen. Three clones contained ␤-galactosidase activity that was much greater than the background level. These three positives were used to perform a back-transformation and confirmed that complementation of histidineindependent growth occurred. When these clones were sequenced, they were shown to have identity to the C/EBP family of transcription factors.
Screen for C/EBP Binding by Electrophoretic Mobility Shift Assay-EMSA was performed to determine which of the C/EBP family members were present in human HepG2 hepatoma cells and which had affinity for the NSRE-1 sequence. The radiolabeled oligonucleotide probe (oligonucleotide-1) corresponded to nt Ϫ79 to Ϫ53 within the human AS proximal promoter and therefore contained the NSRE-1 sequence (nt Ϫ68 to Ϫ60) ( Fig.  1) . Incubation of the NSRE-1 probe with nuclear extract from cells cultured in complete MEM resulted in the formation of three primary complexes (denoted A-C in Fig. 2 ), two of which were detected as faint broad bands, which are often difficult to detect in extracts from cells maintained in complete medium. Inclusion of an excess of the unlabeled NSRE-1 oligonucleotide completely eliminated formation of these three complexes, but also revealed the presence of a nonspecific complex as well (Fig.  2, lane 2) . Formation of complexes A and C was blocked by the presence of an excess of an unlabeled oligonucleotide containing a C/EBP consensus sequence, but complex B remained (Fig.  2, lane 3) . When extracts from cells cultured in the absence of histidine for 16 h were assayed, the amount of each of the specific complexes increased significantly, but the content of complex A was enhanced to the greatest extent (Fig. 2, compare  lanes 4 and 10) . To test for the binding of individual C/EBP family members, antibodies against C/EBP␣, C/EBP␤, C/EBP␦, C/EBP⑀, and CHOP were screened for the ability to supershift these complexes. Antibodies specific for C/EBP␣, C/EBP␦, C/EBP⑀, and CHOP each caused formation of one or more supershifted complexes (denoted by asterisks in Fig. 2 ), but the absolute amount of these complexes was relatively small in both fed and histidine-deprived cells. In contrast, the anti-C/ EBP␤ antibody caused the formation of two shifted complexes that were substantially increased when nuclear extracts from histidine-limited cells were tested (Fig. 2, compare lanes 6 and  12) . It appeared that the primary complex shifted by the anti-C/EBP␤ antibody was complex C (Fig. 2, compare lanes 4 and 6  or lanes 10 and 12) . To show that the C/EBP␤-induced supershift was not cell-specific, experiments were performed using nuclear extracts from human embryonic kidney 293 cells, and similar results were obtained (data not shown).
Addition of increasing amounts of unlabeled NSRE-1 oligonucleotide from 5-to 200-fold demonstrated a concentrationspecific competition for the formation of C/EBP␤ complexes A-C (Fig. 3, lanes 3-7) . Using a 5-200-fold excess of the C/EBPbinding consensus sequence illustrated that complex C was blocked most effectively by the C/EBP sequence, followed by complex B. Complex A formation was the least affected, and a significant amount of the complex remained in the presence of a 200-fold excess of the C/EBP sequence (Fig. 3, lanes 8 -12) . Including the anti-C/EBP␤ antibody illustrated that a 100-fold excess of either the NSRE-1 or C/EBP consensus sequence as an unlabeled competitor prevented formation of the supershifted complex (Fig. 3, lanes 13-15) . (16, 17) are indicated. These include a GC box (GC-III; nt Ϫ109 to Ϫ99) that is not absolutely required for the nutrient-sensing response pathway, but that permits a higher transcription rate in both the basal and starvation-induced states. Also shown are the two cis-acting elements (NSRE-1, nt Ϫ68 to Ϫ60; and NSRE-2, nt Ϫ48 to Ϫ43) that are required for enhanced expression following activation of the AAR or UPR pathway. Below the promoter sequence are shown the two oligonucleotide sequences used for the EMSA studies (Figs. 2-8 ). Oligonucleotide-1 (Oligo-1) contains NSRE-1 only, whereas oligonucleotide-2 (Oligo-2) contains both the NSRE-1 and NSRE-2 sequences.
NSRE-1 Binding of Other Potential Transcription Proteins-

FIG. 2. EMSAs with the human AS promoter NSRE-1 sequence.
Nuclear extracts prepared from HepG2 cells maintained for 16 h in complete MEM (MEM) or histidine-free MEM (ϪHis) were incubated with 32 P-radiolabeled oligonucleotide-1 (see Fig. 1 ). Lane 1 illustrates the effect of including an unrelated sequence as an unlabeled, nonspecific (NS) competitor at a 100-fold excess. Lane 2 represents a 100-fold excess of unlabeled oligonucleotide-1 (Sp), and lane 3 illustrates the effect of a 100-fold excess of the unlabeled C/EBP consensus sequence (C/E; 5Ј-TGCAGATTGCGCAATCTGCA-3Ј). Where indicated, the incubation protocol included no antibody (control (Con)) or an antibody specific for one of the C/EBP family members, as shown above the lanes. CH, CHOP. Arrows A-C denote specific complexes that were increased in amount when extracts from histidine-deprived cells were tested, and the asterisks to the left of a lane indicate supershifted complexes. The autoradiographic film shown is representative of at least two separate experiments using independently prepared nuclear extracts.
gene. As mentioned above, the element within the CHOP promoter that is responsible for this regulation is similar to the NSRE-1 sequence in the AS promoter, but differs by two nucleotides. To determine whether ATF-2 bound to the AS NSRE-1 sequence in vitro, EMSAs were performed in conjunction with supershift assays using an antibody specific for ATF-2 (Figs. 4 and 5) . Although the protein-DNA complexes that are induced following histidine (Fig. 4) or glucose (Fig. 5) deprivation were clearly present, no shifted complexes were detectable after incubation with the anti-ATF-2 antibody with nuclear extracts from cells maintained in MEM (Fig. 4, compare lanes 3 and 4) , histidine-deprived cells (Fig. 4, compare  lanes 8 and 9) , or glucose-deprived cells (Fig. 5, lane 6) . Within the AS NSRE-1 sequence, there is a half-site (5Ј-ATGA-3Ј) for the c-Jun transcription factor, which can dimerize with c-Fos to form the activator protein-1 complex and can also associate with C/EBP␤ (25) . To investigate the possible binding of c-Fos or c-Jun to the NSRE-1 sequence, EMSAs were performed with or without antibodies specific for these two transcription proteins. No evidence could be obtained to suggest that either c-Fos or c-Jun was bound to the NSRE-1 sequence in either fed cells (Fig. 4, lanes 5-7) or histidine-deprived cells (lanes 10 -12) . These results are consistent with data published by Guerrini et al. (14) , who also concluded that this regulatory sequence within the AS promoter does not bind activator protein-1 complexes.
C/EBP␤ Binding Is Also Increased following UPR Activation-The NSRE-1 sequence within the AS promoter differs functionally from the closely related AARE sequence within the CHOP gene because it is also required for activation of the gene by the UPR pathway (17) . To determine whether the abundance of the C/EBP␤-containing NSRE-1 complex was increased following activation of the UPR pathway, HepG2 cells P-radiolabeled oligonucleotide-1 (see Fig. 1 ). Lane 1 shows the complexes that remained in the presence of a 100-fold excess of an unlabeled, nonspecific (NS) sequence, and lane 2 documents "control" complex formation with no competitor added (Con). As indicated above lanes 3-7, competition of the radiolabeled oligonucleotide probe was also tested with the indicated excesses (5-200-fold) of unlabeled oligonucleotide-1 (Oligo-1). Competition by an excess of a C/EBP␤ consensus sequence (see Fig. 1 legend) is illustrated in lanes 8 -12. For lanes [13] [14] [15] , incubation with the anti-C/EBP␤ antibody (Ab) was included in the protocol to effect a supershift, and the impact of including a 100-fold excess of either unlabeled oligonucleotide-1 (lane 14) or the C/EBP␤ consensus sequence (lane 15) was monitored. Arrows A-C denote the starvation-induced complexes that were increased in amount in the extracts from histidine-deprived cells. The data shown are representative of at least two independent experiments using separately prepared nuclear extracts. P-radiolabeled oligonucleotide-1 (see Fig. 1 ) to monitor formation of protein-DNA complexes. Lane 1 shows the complexes that remained in the presence of a 100-fold excess of an unlabeled, nonspecific (NS) sequence, and lane 2 illustrates the competition by including a 100-fold excess of unlabeled oligonucleotide-1 (Sp). As indicated above lanes 3-12, the incubations included no antibody (Control) or an antibody specific for ATF-2, c-Fos, or c-Jun. The data shown are representative of at least two separate experiments using independently prepared nuclear extracts.
FIG. 5.
Formation of C/EBP␤-containing complexes at the NSRE-1 sequence following activation of the UPR pathway by glucose deprivation. Nuclear extracts prepared from HepG2 cells maintained for 16 h in MEM lacking glucose (ϪGlc) were incubated with 32 P-radiolabeled oligonucleotide-1 (see Fig. 1 ) to monitor formation of protein-DNA complexes. Lane 1 shows the complexes that remained if a 100-fold excess of an unlabeled, nonspecific (NS) sequence was added, and lane 2 illustrates the competition of the specific complexes by a 100-fold excess of unlabeled oligonucleotide-1 (Sp) itself. As indicated above lanes 3-12, the additional remaining incubations included no antibody (control (Con)) or an antibody specific for C/EBP␤ (␤), CHOP (CH), or ATF-2. Arrows A-C denote complexes that were increased in amount when extracts from glucose-deprived cells were tested. The data shown are representative of several experiments using independently prepared nuclear extracts.
were subjected to glucose starvation for 16 h, and nuclear extracts were then prepared. EMSAs illustrated that these extracts, when incubated with 32 P-labeled oligonucleotide-1 (NSRE-1), formed the same three induced complexes (Fig. 5 ) as those observed with extracts from histidine-deprived cells (Fig. 2) .
Furthermore, complex C was supershifted by the inclusion of the anti-C/EBP␤ antibody, but not by antibodies specific for CHOP and ATF-2 (Fig. 5) . These results are consistent with previously published observations indicating that the NSRE-1 sequence functions more broadly than an AARE in sensing the nutritional status of the cell (17) .
Relationship between NSRE-1 and NSRE-2 in C/EBP␤ Binding-When an oligonucleotide probe was prepared that corresponded to the AS promoter region containing both the NSRE-1 and NSRE-2 sequences (oligonucleotide-2 (nt Ϫ79 to Ϫ35) in Fig. 1 ), several specific complexes could be detected by EMSAs (Fig. 6) . At least three of these complexes (denoted X-Z in Fig. 6 ) were enhanced in abundance when extracts from histidine-deprived cells were tested (compare lanes 3 and 6) ; and once again, the anti-C/EBP␤ antibody caused a supershift of a major complex (band Z) that was more readily visible in the histidine-depleted cell extracts because of the increased amount (compare lanes 5 and 8). As a negative control in this series of experiments, the anti-C/EBP␣ antibody was also tested. There was a faint supershifted complex that was detectable with the anti-C/EBP␣ antibody (Fig. 6, lane 7) , but it migrated at a slower rate than the complex containing C/EBP␤. To investigate the importance of having both the NSRE-1-and NSRE-2-binding sites present on the same probe, a block of nucleotides within either the NSRE-1 or NSRE-2 core was mutated to a sequence that previous transient transfection functional assays had shown would block regulated transcription (17) . Mutation of the NSRE-1 sequence in the presence of a wild-type NSRE-2 sequence resulted in suppression of the starvation-induced complexes and the anti-C/EBP␤ antibodysupershifted complex (Fig. 6, compare lanes 9 -14) . In contrast, mutation of NSRE-2 and retention of wild-type NSRE-1 resulted in loss of complex X, but formation of the amino acidregulated complexes Y and Z still occurred (Fig. 6, compare  lanes 15 and 18) . As observed for the wild-type sequence, the associated supershift of the Z complex by the anti-C/EBP␤ antibody was detectable when NSRE-2 was mutated (Fig. 6,  lanes 17 and 20) . Therefore, even though both cis-elements are absolutely required for nutrient-regulated transcription as assayed by transient transfection (17) , a nonfunctional NSRE-2 sequence does not prevent C/EBP␤ binding to the NSRE-1 site in vitro. In contrast, in the absence of a functional NSRE-1 sequence, formation of amino acid-sensitive complexes is severely impaired, and no C/EBP␤-containing complexes are detectable.
Mutagenesis of Individual Nucleotides within NSRE-1-In vivo footprinting revealed that the guanine nucleotides at positions Ϫ67 and Ϫ64 within the NSRE-1 sequence show enhanced protection from dimethyl sulfate modification in cells incubated in either histidine-or glucose-depleted medium (17) . Consistent with those results, mutation of individual nucleotides from positions Ϫ68 to Ϫ60 blocks nutrient-dependent transcription of a transiently transfected AS promoter/reporter construct (17) . Therefore, it was predicted that mutation of these nucleotides within the EMSA-radiolabeled NSRE-1 probe should prevent protein binding in vitro. To test this hypothesis, the wild-type NSRE-1 sequence (oligonucleotide-1 in Fig. 1 ) was compared with corresponding 32 P-labeled oligonucleotide probes that had nt Ϫ67, Ϫ64, and Ϫ60 mutated. Using extracts from histidine-fasted cells, we observed that mutation of any one of these three nucleotides decreased protein-DNA complex formation and that the formation of the C/EBP␤-containing complex, shifted by the anti-C/EBP␤ antibody, was completely prevented by mutation of any one of these nucleotides within the NSRE-1 sequence (data not shown). FIG. 6 . Effect of mutating NSRE-1 or NSRE-2 on protein-DNA complex formation. Nuclear extracts prepared from HepG2 cells maintained for 16 h in complete MEM (MEM) or histidine-free MEM (ϪHis) were incubated with 32 P-radiolabeled oligonucleotide-2 (containing both NSRE-1 and NSRE-2, as shown in Fig. 1 ). Complexes that remained in the presence of a 100-fold excess of an unlabeled, nonspecific (NS) sequence are shown in lane 1, and lane 2 illustrates the competition by including a 100-fold excess of unlabeled oligonucleotide-2 (Sp). As indicated above lanes 3-20, the remaining incubations included no antibody (control (C)) or the anti-C/EBP␣ (␣) or anti-C/EBP␤ (␤) antibody to test for C/EBP-containing complexes. The binding site that was mutated within the radiolabeled oligonucleotide-2 probe is indicated below the lanes. WT, wild-type sequence for both NSRE-1 and NSRE-2. The specific nucleotides mutated within each binding site were as follows: for NSRE-1, wild-type sequence ϭ 5ЈATGATGAAAC-3Ј and mutant sequence ϭ 5Ј-ATGCGCTCAC-3Ј; and for NSRE-2, wild-type sequence ϭ 5-GTTACA-3Ј and mutant sequence ϭ 5Ј-GGACGA-3Ј. Arrows X-Z denote complexes that were increased in amount when extracts from histidine-deprived cells were tested, and the asterisks indicate antibody-dependent supershifted complexes. The results shown are representative of several separate experiments using independently prepared nuclear extracts.
Dependence of C/EBP Binding on de Novo Protein Synthesis-
The increase in AS mRNA content following amino acid deprivation is dependent on de novo protein synthesis (11, 12) , consistent with the hypothesis that production of upstream regulators is required prior to transcriptional activation of the AS gene itself. To determine whether C/EBP␤-binding activity was dependent on de novo synthesis, nuclear extracts were prepared from HepG2 cells and incubated in complete MEM or MEM lacking histidine, each with or without cycloheximide. These extracts were then tested by EMSAs for the formation of nutrient-regulated and C/EBP␤-containing protein-DNA complexes (Fig. 7) . Although the absolute amounts of complexes A-C were too low to evaluate the influence of cycloheximide in the cells cultured in complete MEM (Fig. 7, lanes 1 and 5) , histidine deprivation did increase their abundance (compare lanes 1 and 3) , and inhibition of protein synthesis resulted in a complete block of the formation of these complexes (compare lanes 3 and 7) . Furthermore, when the nuclear extracts derived from control and cycloheximide-treated cells were monitored for the ability to form C/EBP␤-containing complexes by antibody supershift, the results clearly documented that de novo protein synthesis was required for formation of the C/EBP␤-containing complexes (Fig. 7, compare lanes 4 and 8) .
Expression of Activating or Inhibitory C/EBP␤ Isoforms Regulates AS Expression--HepG2 cells were transiently cotransfected with a firefly luciferase reporter gene driven by a fragment of the AS proximal promoter (Ϫ115/ϩ1) and a plasmid containing either the activating form of rat C/EBP␤ (LAP) or the dominant-negative inhibitory isoform (LIP), both driven by the cytomegalovirus promoter (22) . The HepG2 cells were transfected and then transferred 48 h later to either complete MEM or MEM lacking histidine or glucose for 12 h prior to the isolation of a cell extract for firefly luciferase analysis (Fig. 8A) . Probing Northern blots to detect the expression of transfected C/EBP␤ revealed that both the activating and inhibitory isoforms were expressed at relatively similar levels (Fig. 8B) .
Consistent with previously published results obtained by transient transfection functional analysis (16, 17) , when the cell extracts were analyzed for luciferase activity, transcription was increased in both the histidine-and glucose-deprived cells that did not receive exogenous C/EBP␤ cDNA (Fig. 8A) . For those cells that were transfected with the LAP form of C/EBP␤, the basal expression (in complete MEM) was increased significantly (Fig. 8A) . Relative to those cells that received vector only, in the cells transfected with LAP, the enhancement following histidine or glucose deprivation was increased. For histidine deprivation, this additional amount of activation was statistically significant. Although the effect in glucose-starved cells did not reach statistical significance, the trend toward higher values in the LAP-expressing cells was reproducible in multiple experiments. In contrast, expression of the dominantnegative LIP form of C/EBP␤ caused an inhibition of basal transcription (cells in MEM) and a complete blockade of the induction by either glucose or histidine deprivation (Fig. 8A) . FIG. 7 . Formation of C/EBP␤-containing NSRE-1 complexes requires de novo protein synthesis during amino acid deprivation. Nuclear extracts were prepared from HepG2 cells maintained for 16 h in complete MEM (MEM) or histidine-free MEM (ϪHis) with (ϩ CHX) or without (Control) 0.1 mM cycloheximide. These extracts were incubated with 32 P-radiolabeled oligonucleotide-1 (containing NSRE-1, as shown in Fig. 1 ) to monitor formation of protein-DNA complexes. As indicated above the lanes, incubations included either no antibody (Ϫ) or the anti-C/EBP␤ antibody (ϩ). The results shown are indicative of multiple independent experiments using different batches of nuclear extracts. NS, nonspecific complex.
FIG. 8. Activating and inhibitory C/EBP␤ isoforms modulate
AS promoter activity accordingly. A, HepG2 cells were transiently transfected with vector containing no cDNA insert (Control), the cDNA for the activating C/EBP␤ isoform (LAP), or the cDNA for the inhibitory C/EBP␤ isoform (LIP). The cells were cotransfected with a vector containing an AS promoter/firefly luciferase reporter construct (to monitor transcription in response to histidine or glucose limitation) and with a vector harboring the Renilla luciferase reporter under the control of the SV40 promoter (to correct for transfection efficiency between dishes). After transfection and culture as described under "Materials and Methods," the cells were incubated for 12 h in complete MEM (MEM) or in MEM lacking glucose (ϪGlc) or histidine (ϪHis), and then cell extracts were analyzed for both luciferase activities. The data shown are the means Ϯ S.D. of four individual assays (corrected by calculating the ratio of firefly activity to Renilla activity), which were repeated for multiple independent transfections. The results were normalized by assigning the value for the control cells (no C/EBP␤) incubated in MEM to be equal to 1.0. The p values (*, p Ͻ 0.05; **, p Յ 0.005) for C/EBP-transfected cell populations were calculated relative to the corresponding control values and determined by Student's t test. B, following transfection of HepG2 cells with vector containing either LAP or LIP cDNA, RNA was also isolated, and Northern blots were probed for C/EBP mRNA to confirm expression of both isoforms. Endogenous human C/EBP␤ (e-C/EBP) was detected, as were the rat LAP and LIP isoforms.
To address the possibility that glucose or histidine limitation altered biosynthesis of firefly luciferase, a parallel series of experiments was performed in which firefly luciferase mRNA was measured by Northern analysis. Following glucose starvation, the induction of firefly mRNA (2.7-fold) and activity (3.0-fold) was indistinguishable, whereas histidine limitation reduced the enzymatic activity (5-fold) by ϳ50% relative to the mRNA content (10-fold). Therefore, the observed increase in firefly activity (shown in Fig. 8 ) actually represents an underestimation of the transcriptional activation by LAP C/EBP␤ in the AS gene. Collectively, these data are consistent with the in vitro EMSA studies described above and document that C/EBP␤ serves in vivo as a mediator of the nutrient-sensing response pathway.
DISCUSSION
The results presented in this report document that C/EBP␤ binds to the NSRE-1 cis-element within the proximal promoter of the human AS gene and is involved in the activation of the gene in response to nutrient deprivation. NSRE-1 is one of two cis-elements (the other being NSRE-2) that are required for increased transcription of the AS gene following activation of either the AAR or UPR pathway (15) (16) (17) . We have coined the phrase nutrient-sensing response unit to describe this set of elements that function together to regulate transcription of this gene in response to nutrient availability.
The yeast one-hybrid results and the EMSA data indicate that C/EBP␤ binds to the NSRE-1 sequence. Functional assays have illustrated that this cis-element is required for induction of the AS gene in response to activation of either the AAR or UPR pathway (17) . Furthermore, in vivo footprinting documented that nutrient limitation causes an increase in protein binding at NSRE-1 (17) . Consistent with these results, the present data indicated that C/EBP␤ binding was increased when nuclear extracts from either histidine-or glucose-deprived cells were tested. Following nutrient removal from the culture medium, there is a lag of 2-4 h prior to a significant increase in AS mRNA content (12, 15) , and the increased abundance of AS mRNA is dependent on de novo protein synthesis (12, 26) . These data suggest that synthesis of an upstream regulator is required prior to activation of AS gene transcription. Inhibition of protein synthesis prevented the starvationdependent increase in protein-DNA complex formation as assayed by EMSAs and, interestingly, completely eliminated C/EBP␤-binding activity in the nuclear extracts. These results suggest that C/EBP␤ itself or a protein at a prior step in the pathway must be synthesized de novo for a robust response to occur in the AS gene following activation of either the AAR or UPR pathway. Regulated translation of an upstream signal protein would be consistent with the yeast general control non-depressible (GCN) pathway, in which amino acid starvation results in selective translation of Gcn4 mRNA (27) . This translational control mechanism requires activation of the Gcn2 kinase, and a mammalian homolog with properties similar to those of yeast Gcn2 has been identified (28) . However, it appears that mammalian cells may have more than one amino acid signaling pathway (29, 30) , so the possible involvement of Gcn2 in AS gene activation will need to be verified.
Two lines of evidence document that C/EBP␤ functions in vivo to regulate transcription of the AS gene. First, basal transcription was induced in C/EBP␤-overexpressing cells, and nutrient-induced transcription from the AS promoter fragment was enhanced even further by C/EBP␤ expression. Second, expression of the LIP isoform of C/EBP␤ caused a significant inhibition of basal (complete MEM) transcription and completely prevented the induction following either histidine or glucose deprivation. Collectively, the data provide strong support for the proposed role of C/EBP␤ as a transcriptional regulator for the nutrient-sensing response pathway that represents a convergence of the AAR and UPR pathways at the human AS gene.
The C/EBP transcription proteins represent a subclass of the basic leucine zipper family of transcription proteins, and most have been shown to homodimerize, to heterodimerize with other C/EBP family members, or to heterodimerize with other basic leucine zipper family members (31, 32) . Furthermore, the C/EBP␤ gene gives rise to different isoforms. One of the forms of C/EBP␤ identified initially was referred to as liver-enriched activating protein because it was first shown to be a potent enhancer of liver gene expression (22) . A shorter isoform of C/EBP␤ corresponds to the C-terminal portion of LAP and lacks the transactivation domain, but contains the basic leucine zipper region. As a result, this isoform, referred to as liver-enriched inhibitory protein, acts as a dominant-negative repressor of C/EBP␤ function. For example, expression of LIP can override LAP C/EBP␤-dependent cell cycle arrest in hepatoma cells (33) .
Fafournoux et al. (7) have described an AARE within the 5Ј-upstream region of the human CHOP gene that differs from the NSRE-1 sequence in the AS proximal promoter by two nucleotides. These authors demonstrated that although both C/EBP␤ and ATF-2 bind this sequence in vitro (20) , when knockout cell lines for these two proteins are tested, amino acid-dependent expression of the gene is blocked in the ATF-2 Ϫ/Ϫ cells, but not in those cells lacking C/EBP␤ expression. This result was supported by the observation that expression of a dominant-negative form of ATF-2 suppresses the starvationdependent transcription from a CHOP promoter/luciferase reporter construct (20) . The present EMSA studies demonstrated that ATF-2 did not bind to the AS NSRE-1 sequence, despite the fact that a positive control with a cAMP response elementbinding protein/ATF consensus oligonucleotide showed that these extracts had the ability to form ATF-2 complexes. There are several additional lines of evidence suggesting that induction of AS and CHOP following amino acid deprivation occurs by different mechanisms. 1) The NSRE-1 sequence is required for activation of the AS gene following either amino acid limitation or activation of the UPR pathway (17) , whereas the cis-acting elements required for induction of the CHOP gene following amino acid deprivation or activation of the UPR pathway are located in sequences separated by several hundred base pairs (21, 34) . 2) Fafournoux and co-workers (13) have shown that the amino acid specificity with regard to the degree of induction of these two genes is different. 3) Within the CHOP promoter, there is a sequence (5Ј-CCAATCAGAAAGTG-GCACG-3Ј, nt Ϫ75 to Ϫ93) that activates the gene in response to the UPR pathway (21); the AS promoter lacks this consensus sequence (17) . 4) The region immediately following the CHOP AARE does not have a readily identifiable sequence that would correspond to NSRE-2. 5) The abundance of the ATF-2-and C/EBP␤-containing complexes, detected by EMSAs using the CHOP AARE sequence, does not increase when nuclear extracts from amino acid-deprived cells are tested (20) , whereas the C/EBP␤-containing complexes with NSRE-1 do increase. Collectively, the properties of the AARE for the CHOP gene and AS NSRE-1 demonstrate that they are structurally related, but functionally distinct.
The mechanisms for control of transcription in mammalian cells by intermediary metabolites that can initiate cellular signals and thereby reflect nutrient availability are not well understood for most molecules, amino acids and glucose included. By first identifying the genomic cis-elements and then the corresponding transcription proteins responsible for regu-lation of specific target genes, it is anticipated that one can progress backwards up the signal transduction pathway to understand the individual steps required. For the human AS gene, this strategy has revealed that two independent metabolic sensing pathways, one that detects amino acid limitation and one that senses glucose deprivation, converge and act at the promoter through a common set of genomic elements (16, 17) . The present results document that one of the transcriptional regulators associated with this process is C/EBP␤. The identification of C/EBP␤, a known regulator of many other metabolic and cellular differentiation pathways, provides the foundation on which to continue the investigation of this metabolite control pathway.
